SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2015

Por García-Campelo, R., Bernabé, R., Cobo, M., Corral, J., Coves, J., Dómine, M., Nadal, E., Rodriguez-Abreu, D., Viñolas, N., Massuti, B.
Publicado no Clin Transl Oncol (2015)

In vitro biochemical and in vivo biological studies of the uridine 'rescue' of 5-fluorouracil.

Por Peters, G. J., van Dijk, J., Laurensse, E., van Groeningen, C. J., Lankelma, J., Leyva, A., Nadal, J. C., Pinedo, H. M.
Publicado em 1988

TLR9 agonists induced cell death in Burkitt's lymphoma cells is variable and influenced by TLR9 polymorphism

Por Noack, J, Jordi, M, Zauner, L, Alessi, D, Burch, A, Tinguely, M, Hersberger, M, Bernasconi, M, Nadal, D
Publicado em 2012

EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer

Por Serrano, Maria J., Ortega, Francisco G., Alvarez-Cubero, Maria J., Nadal, Rosa, Sanchez-Rovira, Pedro, Salido, Marta, Rodríguez, María, García-Puche, Jose L., Delgado-Rodriguez, Miguel, Solé, Francisco, García, Maria A., Perán, Macarena, Rosell, Rafael, Marchal, Juan A., Lorente, Jose A.
Publicado em 2014

Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy

Por Bergamino, Milana, Rullan, Antonio J., Saigí, Maria, Peiró, Inmaculada, Montanya, Eduard, Palmero, Ramón, Ruffinelli, José Carlos, Navarro, Arturo, Arnaiz, María Dolores, Brao, Isabel, Aso, Samantha, Padrones, Susana, Cardenal, Felipe, Nadal, Ernest
Publicado no BMC Cancer (2019)

Dual MET and ERBB inhibition overcomes intratumor plasticity in osimertinib-resistant-advanced non-small-cell lung cancer (NSCLC)

Por Martinez-Marti, A, Felip, E, Matito, J, Mereu, E, Navarro, A, Cedrés, S, Pardo, N, Martinez de Castro, A, Remon, J, Miquel, J M, Guillaumet-Adkins, A, Nadal, E, Rodriguez-Esteban, G, Arqués, O, Fasani, R, Nuciforo, P, Heyn, H, Villanueva, A, Palmer, H G, Vivancos, A
Publicado no Ann Oncol (2017)

Geriatric assessment may help decision-making in elderly patients with inoperable, locally advanced non-small-cell lung cancer

Por Antonio, Maite, Saldaña, Juana, Linares, Jennifer, Ruffinelli, José C, Palmero, Ramón, Navarro, Arturo, Arnaiz, Maria Dolores, Brao, Isabel, Aso, Samantha, Padrones, Susana, Navarro, Valentí, González-Barboteo, Jesús, Borràs, Josep Maria, Cardenal, Felipe, Nadal, Ernest
Publicado no Br J Cancer (2018)

A Prospective Multicenter Study of Microbiologically Defined Infections in Pediatric Cancer...

Por Agyeman, Philipp, Kontny, Udo, Nadal, David, Leibundgut, Kurt, Niggli, Felix, Simon, Arne, Kronenberg, Andreas, Frei, Reno, Escobar, Hugo, Kühne, Thomas, Beck-Popovic, Maja, Bodmer, Nicole, Ammann, Roland A.
Publicado em 2014

Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer

Por Borrero-Palacios, A., Cebrián, A., Gómez del Pulgar, M. T., García-Carbonero, R., Garcia-Alfonso, P., Aranda, E., Elez, E., López-López, R., Cervantes, A., Valladares, M., Nadal, C., Viéitez, J. M., Guillén-Ponce, C., Rodríguez, J., Hernández, I., García, J. L., Vega-Bravo, R., Puime-Otin, A., Martínez-Useros, J., Del Puerto-Nevado, L., Rincón, R., Rodríguez-Remírez, M., Rojo, F., García-Foncillas, J.
Publicado no Sci Rep (2019)

High Histologic Grade and High Ki-67 Expression Predict Phenotypic Alterations in Node Metastasis in Primary Breast Cancers

Por Mandó, Pablo, Rizzo, Manglio, de la Puente, Constanza Perez, Maino, Mercedes, Ponce, Carolina, Pombo, Maria Teresa, Amat, Mora, Costanzo, Maria Victoria, Nervo, Adrian, Nadal, Jorge, Fabiano, Veronica, Loza, Jose, Loza, Carlos Martin, Colo, Federico, Reinaldo, Chacon
Publicado no J Breast Cancer (2017)